HomeNAMS • NASDAQ
add
NewAmsterdam Pharma Company NV
Previous close
$34.28
Day range
$33.41 - $35.51
Year range
$14.06 - $41.91
Market cap
4.04B USD
Avg Volume
675.96K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 32.00K | -99.75% |
Operating expense | 66.01M | 17.88% |
Net income | -74.92M | 18.72% |
Net profit margin | -234.13K | -32,341.62% |
Earnings per share | — | — |
EBITDA | -65.92M | -52.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 636.24M | -23.73% |
Total assets | 769.28M | -11.03% |
Total liabilities | 85.85M | -19.85% |
Total equity | 683.43M | — |
Shares outstanding | 114.98M | — |
Price to book | 5.74 | — |
Return on assets | -21.21% | — |
Return on capital | -23.36% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -74.92M | 18.72% |
Cash from operations | -40.88M | -9.06% |
Cash from investing | -21.14M | 66.00% |
Cash from financing | 13.68M | -97.00% |
Net change in cash | -48.39M | -113.87% |
Free cash flow | -9.77M | -128.72% |
About
Founded
2019
Website
Employees
100